Hedge Funds Are Selling VIVUS, Inc. (VVUS)

Is VIVUS, Inc. (NASDAQ:VVUS) a good investment today? Money managers are in a pessimistic mood. The number of long hedge fund bets stayed the same which is a slightly negative development in our experience

In the financial world, there are tons of methods shareholders can use to track their holdings. Two of the most underrated are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can trounce the broader indices by a superb margin (see just how much).

Equally as integral, positive insider trading sentiment is a second way to break down the stock market universe. Obviously, there are lots of reasons for a bullish insider to sell shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Many empirical studies have demonstrated the valuable potential of this strategy if investors understand where to look (learn more here).

Keeping this in mind, it’s important to take a glance at the latest action encompassing VIVUS, Inc. (NASDAQ:VVUS).

How are hedge funds trading VIVUS, Inc. (NASDAQ:VVUS)?

In preparation for this quarter, a total of 21 of the hedge funds we track held long positions in this stock, a change of 0% from the previous quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their holdings significantly.

VIVUS, Inc. (NASDAQ:VVUS)According to our comprehensive database, Passport Capital, managed by John Burbank, holds the biggest position in VIVUS, Inc. (NASDAQ:VVUS). Passport Capital has a $105.1 million position in the stock, comprising 4.2% of its 13F portfolio. On Passport Capital’s heels is Daniel Gold of QVT Financial, with a $91.8 million position; the fund has 6.1% of its 13F portfolio invested in the stock. Other hedgies that hold long positions include Richard Chilton’s Chilton Investment Company, Ken Griffin’s Citadel Investment Group and Scott McLellan’s Marble Arch Investments.

Due to the fact that VIVUS, Inc. (NASDAQ:VVUS) has faced falling interest from the aggregate hedge fund industry, it’s safe to say that there exists a select few hedge funds that slashed their full holdings last quarter. Intriguingly, Daniel Arbess’s Xerion said goodbye to the largest position of the 450+ funds we track, totaling about $20.8 million in call options, and Kyle Bass of Hayman Advisors was right behind this move, as the fund cut about $20.7 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about VIVUS, Inc. (NASDAQ:VVUS)?

Insider trading activity, especially when it’s bullish, is particularly usable when the company in question has seen transactions within the past 180 days. Over the last half-year time frame, VIVUS, Inc. (NASDAQ:VVUS) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to VIVUS, Inc. (NASDAQ:VVUS). These stocks are MannKind Corporation (NASDAQ:MNKD), PDL BioPharma Inc. (NASDAQ:PDLI), Sarepta Therapeutics Inc (NASDAQ:SRPT), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), and Santarus, Inc. (NASDAQ:SNTS). This group of stocks are in the biotechnology industry and their market caps resemble VVUS’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
MannKind Corporation (NASDAQ:MNKD) 6 2 2
PDL BioPharma Inc. (NASDAQ:PDLI) 13 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 19 0 1
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) 9 0 0
Santarus, Inc. (NASDAQ:SNTS) 15 1 14

With the returns demonstrated by the aforementioned strategies, everyday investors should always watch hedge fund and insider trading sentiment, and VIVUS, Inc. (NASDAQ:VVUS) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!